$AIP

Viana Antonio J sold $761K of AIP (indirect holdings)

Viana Antonio J sold 20,839 indirectly-held shares of Arteris, Inc. (AIP) at an average of $36.51 ($35.47–$37.09, $0.76M total) across 3 trades on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Viana Antonio J
Published Jun 5, 2026, 10:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 4:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Bearish
medium confidence
Mentioned
$AIP
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPBearishLow
01

Why it matters

A director's sale may slightly depress the stock but is unlikely to drive major moves.

02

Market read

Routine insider sale with modest size; limited trading relevance.

03

What to watch

The director retains a sizable holding, suggesting continued confidence.

Relevance 4/10Novelty 4/10Timing: post-market on 2026-06-05

Background

Form 4 filing discloses insider transactions required by the SEC.

Company-level read

Ticker impact

$AIPBearishMedium confidence
Context

Director Viana Antonio J sold 20,839 shares for $760.9K via a 10b5-1 plan, reducing his stake to 64,620 shares.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

A $760K sale by a director is a routine but material transaction that can signal short-term downside.

Market effects

Minimal impact on the semiconductor IP sector.

No significant regional effect.

Limited relevance beyond the company.

Counterpoint

The sale could be a routine liquidity move and not indicative of future performance.

Key entities

  • Arteris, Inc.

    Provider of semiconductor IP, ticker AIP.

  • Viana Antonio J

    Director of Arteris who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to